{"id":47866,"date":"2020-07-31T05:30:05","date_gmt":"2020-07-31T10:30:05","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&#038;p=47866"},"modified":"2020-08-31T09:03:20","modified_gmt":"2020-08-31T14:03:20","slug":"taking-action","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/","title":{"rendered":"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie"},"content":{"rendered":"<h2>\u00c9l\u00e9ments cl\u00e9s \u00e0 retenir<\/h2>\n<ul>\n<li>Les taux de rappel pour anomalie (TRA) pour le d\u00e9pistage du cancer du sein ont augment\u00e9 r\u00e9guli\u00e8rement au cours des dix derni\u00e8res ann\u00e9es, d\u00e9passant la cible canadienne et les cibles internationales en la mati\u00e8re.<\/li>\n<li>En d\u00e9pit de cette hausse des TRA, les taux de d\u00e9tection de cancers (TDC) sont rest\u00e9s stables. Un TRA \u00e9lev\u00e9, en l\u2019absence d\u2019une augmentation correspondante du TDC, signifie qu\u2019un plus grand nombre de personnes subissent des examens de suivi, sans aucun avantage suppl\u00e9mentaire.<\/li>\n<li>Les TRA varient selon les provinces et les territoires, donnant \u00e0 penser qu\u2019il existe des diff\u00e9rences entre les programmes de d\u00e9pistage et entre les pratiques d\u2019assurance de la qualit\u00e9.<\/li>\n<li>Au fur et \u00e0 mesure des progr\u00e8s des technologies de d\u00e9pistage du cancer du sein, il est possible qu\u2019il soit n\u00e9cessaire de faire \u00e9voluer les cibles canadiennes en mati\u00e8re de TRA, afin de maintenir les avantages du d\u00e9pistage.<\/li>\n<li>\u00c0 mesure que le Canada reprendra les services de d\u00e9pistage apr\u00e8s la pand\u00e9mie de COVID-19, il faudra les planifier minutieusement, afin de veiller \u00e0 ne pas d\u00e9passer les capacit\u00e9s du syst\u00e8me.<\/li>\n<\/ul>\n<h2>Application du Cadre<\/h2>\n<p>La plupart des personnes subissant une mammographie n\u2019auront pas de cancer du sein. Des r\u00e9sultats de d\u00e9pistage plus rigoureux contribuent \u00e0 garantir que celles-ci ne souffrent ni d\u2019un stress ni de pr\u00e9judices inutiles, du fait d\u2019examens de suivi dont elles n\u2019ont pas besoin.<\/p>\n<p>De gros efforts ont \u00e9t\u00e9 accomplis pour am\u00e9liorer la qualit\u00e9 des mammographies de d\u00e9pistage au Canada. La r\u00e9duction des taux de rappel pour anomalie (TRA) contribuera \u00e0 p\u00e9renniser ces am\u00e9liorations et garantira la prestation continue de services de d\u00e9pistage de haute qualit\u00e9. Le <a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Framework-for-action-ACR-breast-screening-FR.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Cadre d\u2019action pancanadien pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein<\/a> peut aider les programmes de d\u00e9pistage du cancer du sein \u00e0 adopter des approches fond\u00e9es sur des donn\u00e9es probantes pour optimiser leur TRA. Ces approches contribueront \u00e0 maximiser les avantages du d\u00e9pistage, tout en r\u00e9duisant au minimum les inconv\u00e9nients pour les patientes et les co\u00fbts pour les syst\u00e8mes de sant\u00e9.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-47963\" src=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg\" alt=\"Icones six approaches\" width=\"1219\" height=\"656\" srcset=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg 1219w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR-300x161.jpg 300w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR-1024x551.jpg 1024w, https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR-768x413.jpg 768w\" sizes=\"auto, (max-width: 1219px) 100vw, 1219px\" \/><\/p>\n<p>Les programmes de d\u00e9pistage peuvent mettre en \u0153uvre les approches du Cadre, \u00e0 court terme, \u00e0 moyen terme et \u00e0 long terme, en fonction de leurs propres capacit\u00e9s et des ressources dont ils disposent. Ce faisant, il est important d\u2019appliquer un prisme d\u2019\u00e9quit\u00e9 dans l\u2019allocation des fonds et des ressources disponibles, permettant ainsi de r\u00e9duire les lacunes existantes dans l\u2019acc\u00e8s \u00e0 un d\u00e9pistage de haute qualit\u00e9. Les valeurs des participantes aux programmes de d\u00e9pistage doivent \u00e9galement \u00eatre prises en compte lors de la d\u00e9termination de l\u2019\u00e9quilibre acceptable entre les TRA et les TDC.<\/p>\n<p><strong>Document \u00e0 t\u00e9l\u00e9charger<\/strong><\/p>\n<div class=\"documents col-md-12\"><div>\n                                <i class=\"fas fa-file-pdf document-icon\"><\/i>\n                                <div class=\"document-details\">\n                                    <a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Framework-for-action-ACR-breast-screening-FR.pdf\" target=\"_blank\">Cadre d'action pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein<\/a><p class=\"file-information\">Taille du fichier 6 MB<\/p>         <\/div>\n                            <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00c9l\u00e9ments cl\u00e9s \u00e0 retenir Les taux de rappel pour anomalie (TRA) pour le d\u00e9pistage du cancer du sein ont augment\u00e9 r\u00e9guli\u00e8rement au cours des dix derni\u00e8res ann\u00e9es, d\u00e9passant la cible canadienne et les cibles internationales en la mati\u00e8re. En d\u00e9pit de cette hausse des TRA, les taux de d\u00e9tection de cancers (TDC) sont rest\u00e9s stables. [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":47860,"menu_order":2,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-47866","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"\u00c9l\u00e9ments cl\u00e9s \u00e0 retenir Les taux de rappel pour anomalie (TRA) pour le d\u00e9pistage du cancer du sein ont augment\u00e9 r\u00e9guli\u00e8rement au cours des dix derni\u00e8res ann\u00e9es, d\u00e9passant la cible canadienne et les cibles internationales en la mati\u00e8re. En d\u00e9pit de cette hausse des TRA, les taux de d\u00e9tection de cancers (TDC) sont rest\u00e9s stables. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-31T14:03:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/\",\"name\":\"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Six-circlers-FR.jpg\",\"datePublished\":\"2020-07-31T10:30:05+00:00\",\"dateModified\":\"2020-08-31T14:03:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Six-circlers-FR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2020\\\/08\\\/Six-circlers-FR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/taking-action\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/abnormal-call-rates-breast-cancer-screening\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/","og_locale":"fr_FR","og_type":"article","og_title":"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie - Canadian Partnership Against Cancer","og_description":"\u00c9l\u00e9ments cl\u00e9s \u00e0 retenir Les taux de rappel pour anomalie (TRA) pour le d\u00e9pistage du cancer du sein ont augment\u00e9 r\u00e9guli\u00e8rement au cours des dix derni\u00e8res ann\u00e9es, d\u00e9passant la cible canadienne et les cibles internationales en la mati\u00e8re. En d\u00e9pit de cette hausse des TRA, les taux de d\u00e9tection de cancers (TDC) sont rest\u00e9s stables. [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2020-08-31T14:03:20+00:00","og_image":[{"url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/","name":"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/#primaryimage"},"image":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/#primaryimage"},"thumbnailUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg","datePublished":"2020-07-31T10:30:05+00:00","dateModified":"2020-08-31T14:03:20+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/#primaryimage","url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg","contentUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Six-circlers-FR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/taking-action\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Cadre pour optimiser les taux de rappel pour anomalie dans le d\u00e9pistage du cancer du sein","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/abnormal-call-rates-breast-cancer-screening\/"},{"@type":"ListItem","position":3,"name":"Agir en vue d\u2019am\u00e9liorer les taux de rappel pour anomalie"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/47866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/47860"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=47866"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=47866"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=47866"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=47866"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=47866"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=47866"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=47866"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=47866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}